Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARC BLOOMENSTEIN

Eye and Vision Services Providers Optometrist

NPI
1568428910
CMS profile
25861
Location
SCOTTSDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$130,158.94

245 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 5; records 51–100 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MARC BLOOMENSTEIN

NPI 1568428910 · CMS profile ID 25861

Eye and Vision Services Providers / Optometrist

SCOTTSDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1568428910?year=2019&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MARC BLOOMENSTEIN, NPI 1568428910, CMS profile ID 25861. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1568428910?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). MARC BLOOMENSTEIN, NPI 1568428910, CMS profile ID 25861. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1568428910?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
MARC BLOOMENSTEIN, NPI 1568428910, CMS profile ID 25861, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1568428910?year=2019&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

245 matching records · $130,158.94 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 245 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 245.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Bausch & Lomb, a division of Bausch Health US, LLC $21.3511/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684386615 CMS
Johnson & Johnson Surgical Vision, Inc. $6,750.0010/29/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932789 CMS
Allergan Inc. $6.2410/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131353 CMS
Allergan Inc. $31.2010/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131355 CMS
Allergan Inc. $27.0010/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131357 CMS
Allergan Inc. $124.1010/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131359 CMS
Allergan Inc. $619.6010/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131361 CMS
Allergan Inc. $134.4710/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131363 CMS
Allergan Inc. $2,500.0010/18/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131365 CMS
Allergan Inc. $23.9610/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131367 CMS
Allergan Inc. $17.3210/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131351 CMS
Johnson & Johnson Surgical Vision, Inc. $6,750.0010/14/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932791 CMS
Sun Pharmaceutical Industries Inc. $5.0710/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704590467 CMS
Johnson & Johnson Surgical Vision, Inc. $52.7110/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932785 CMS
Johnson & Johnson Surgical Vision, Inc. $2,000.6810/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932787 CMS
Johnson & Johnson Surgical Vision, Inc. $54.8110/01/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932793 CMS
Reichert, Inc. $500.0010/01/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 623745913 CMS
Allergan Inc. $50.0009/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131349 CMS
Johnson & Johnson Surgical Vision, Inc. $50.0009/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932761 CMS
Johnson & Johnson Surgical Vision, Inc. $35.0009/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932769 CMS
Johnson & Johnson Surgical Vision, Inc. $35.0009/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932771 CMS
Johnson & Johnson Surgical Vision, Inc. $23.7909/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932773 CMS
Johnson & Johnson Surgical Vision, Inc. $417.9409/27/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932755 CMS
Johnson & Johnson Surgical Vision, Inc. $3.2609/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932763 CMS
Johnson & Johnson Surgical Vision, Inc. $41.6809/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932775 CMS
Dompe US, Inc. $121.9009/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703174849 CMS
Johnson & Johnson Surgical Vision, Inc. $3.5009/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932765 CMS
Allergan Inc. $6.7309/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131347 CMS
Johnson & Johnson Surgical Vision, Inc. $1,298.9709/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932753 CMS
Johnson & Johnson Surgical Vision, Inc. $30.3609/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932759 CMS
Johnson & Johnson Surgical Vision, Inc. $49.9009/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932767 CMS
Johnson & Johnson Surgical Vision, Inc. $34.5009/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932777 CMS
Johnson & Johnson Surgical Vision, Inc. $66.4209/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932779 CMS
Johnson & Johnson Surgical Vision, Inc. $123.9609/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932757 CMS
Johnson & Johnson Surgical Vision, Inc. $29.0709/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655932781 CMS
TissueTech, Inc. $66.5809/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 698622551 CMS
Bausch & Lomb, a division of Bausch Health US, LLC $4.5109/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684386613 CMS
Allergan Inc. $3.7609/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131345 CMS
Sun Pharmaceutical Industries Inc. $258.7709/13/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704590539 CMS
Sun Pharmaceutical Industries Inc. $401.6009/13/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704590541 CMS
Sun Pharmaceutical Industries Inc. $76.0309/13/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704590543 CMS
Sun Pharmaceutical Industries Inc. $4,700.0009/13/2019 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 704590545 CMS
Allergan Inc. $2.6509/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131309 CMS
Allergan Inc. $2.7509/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131311 CMS
Allergan Inc. $34.8009/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131313 CMS
Allergan Inc. $4.0009/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131315 CMS
Allergan Inc. $17.4809/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131317 CMS
Allergan Inc. $14.6409/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131319 CMS
Allergan Inc. $5.2509/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131321 CMS
Allergan Inc. $20.0309/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131323 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $130,158.94 245
PY2020 $96,639.41 172
PY2021 $216,426.85 349
PY2022 $229,537.97 346
PY2023 $216,139.27 336
PY2024 $181,786.01 278
PY2025 $294,464.50 423

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $264,073.50 27
PY2024 Principal investigator $148,060.00 10
PY2023 Principal investigator $65,884.50 3
PY2022 Principal investigator $235,930.50 6
PY2021 Principal investigator $112,295.00 3
PY2020 Principal investigator $28,116.14 13
PY2019 Principal investigator $48,967.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

27 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Oyster Point Pharma, Inc. $1,016.00 12/16/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) No dispute reported 06/30/2026 1238523014
Principal investigator 1 Oyster Point Pharma, Inc. $1,316.00 12/12/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522992
Principal investigator 1 Oyster Point Pharma, Inc. $11,536.00 12/12/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523042
Principal investigator 1 Oyster Point Pharma, Inc. $2,632.00 11/17/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522996
Principal investigator 1 Oyster Point Pharma, Inc. $6,460.00 11/17/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) No dispute reported 06/30/2026 1238523018
Principal investigator 1 Oyster Point Pharma, Inc. $8,168.00 10/16/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) No dispute reported 06/30/2026 1238523012
Principal investigator 1 Oyster Point Pharma, Inc. $13,316.00 10/16/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (VEGA-3) No dispute reported 06/30/2026 1238523016
Principal investigator 1 Oyster Point Pharma, Inc. $3,948.00 10/15/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522994
Principal investigator 1 Oyster Point Pharma, Inc. $2,500.00 10/15/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523040
Principal investigator 1 Oyster Point Pharma, Inc. $2,680.00 09/29/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238523006
Principal investigator 1 Oyster Point Pharma, Inc. $3,948.00 09/15/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523036
Principal investigator 1 Oyster Point Pharma, Inc. $11,964.00 08/22/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238523010
Principal investigator 1 Oyster Point Pharma, Inc. $2,632.00 08/18/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523038
Principal investigator 1 Oyster Point Pharma, Inc. $12,450.00 07/23/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238523008
Principal investigator 1 Oyster Point Pharma, Inc. $8,554.00 07/23/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523034
Principal investigator 1 Oyster Point Pharma, Inc. $7,508.00 06/12/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523032
Principal investigator 1 Oyster Point Pharma, Inc. $7,230.00 06/10/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238522998
Principal investigator 1 Oyster Point Pharma, Inc. $8,718.00 05/01/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238523000
Principal investigator 1 Oyster Point Pharma, Inc. $11,786.00 04/29/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523028
Principal investigator 1 Oyster Point Pharma, Inc. $16,088.00 04/01/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238523002
Principal investigator 1 Oyster Point Pharma, Inc. $16,090.00 04/01/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (LYNX-2) No dispute reported 06/30/2026 1238523004
Principal investigator 1 Oyster Point Pharma, Inc. $11,252.00 04/01/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523024
Principal investigator 1 Sight Sciences, Inc. $35,433.50 03/20/2025 Non-covered Recipient Entity
MRB Eye Consultants
Prospective Randomized Masked Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare System in the Treatment of the Signs and Symptoms of Dry Eye Disease (SAHARA) No dispute reported 06/30/2026 1244586207
Principal investigator 1 Oyster Point Pharma, Inc. $7,358.00 02/14/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523026
Principal investigator 1 Oyster Point Pharma, Inc. $14,750.00 02/14/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523030
Principal investigator 1 Oyster Point Pharma, Inc. $18,142.00 01/13/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523020
Principal investigator 1 Oyster Point Pharma, Inc. $16,598.00 01/13/2025 Non-covered Recipient Entity
MRB Eye Consultants, LLC
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) No dispute reported 06/30/2026 1238523022